Severe Chronic Obstructive Pulmonary Disease
Showing 1 - 25 of >10,000
COPD Trial (Nitric Oxide Generation and Delivery System)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Nitric Oxide Generation and Delivery System
- (no location specified)
Jun 1, 2023
COPD Trial (HRG2005 inhalation, Placebo to match HRG2005 inhalation, Placebo to match Indacaterol Maleate and Glycopyrronium
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- HRG2005 inhalation
- +3 more
- (no location specified)
Sep 7, 2023
Respiratory and Cardiovascular Alterations in Chronic
Recruiting
- Chronic Obstructive Pulmonary Disease Moderate
- +3 more
-
Kaunas, LithuaniaLithuanian University of Health Sciences
Oct 8, 2023
Pulmonary Disease, Chronic Obstructive Trial in Beijing, Shenzhen, Shanghai (611 300 mg Q2W, 611 450 mg Q2W, Matching )
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- 611 300 mg Q2W
- +2 more
-
Beijing, Beijing, China
- +2 more
Oct 25, 2023
COPD Trial in Guangzhou (Ensifentrine, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Ensifentrine
- Placebo
-
Guangzhou, Guangdong, China1st Affiliated Hospital of Guangzhou Medical University
Feb 28, 2023
COPD Trial in Hillerød (Intervention)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Intervention
-
Hillerød, DenmarkNordsjællands Hospital
Dec 12, 2022
COPD Trial in China (TQC3721 suspension for inhalation, TQC3721 matching for inhalation, Salbutamol sulfate inhalation aerosol)
Recruiting
- Chronic Obstructive Pulmonary Disease
- TQC3721 suspension for inhalation
- +2 more
-
Guangzhou, Guangdong, China
- +10 more
Aug 4, 2023
COPD Severe Trial in London (Auto-titrating non-invasive ventilation)
Suspended
- Chronic Obstructive Pulmonary Disease Severe
- Auto-titrating non-invasive ventilation
-
London, United KingdomGuys and St Thomas NHS Foundation Trust
Dec 29, 2022
Phenotypes in Severe Chronic Obstructive Pulmonary Disease
Completed
- Severe COPD
- NA: no intervention
- (no location specified)
Feb 25, 2022
COPD (COPD) Trial (AZD4831, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- AZD4831
- Placebo
- (no location specified)
Aug 5, 2022
Real-world, 52-week Prospective Study to Capture Reasons for
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive (COPD)
- Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
- (no location specified)
Jun 13, 2023
Pulmonary Hypertension, COPD Trial (Tadalafil)
Not yet recruiting
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- (no location specified)
Apr 25, 2023
Severe COPD Trial in Anderlecht (Standard Occupational Therapy, Occupational Therapy with Breathing Control Exercises)
Recruiting
- Severe Chronic Obstructive Pulmonary Disease
- Standard Occupational Therapy
- Occupational Therapy with Breathing Control Exercises
-
Anderlecht, BelgiumJ Bracops Hospital
Apr 6, 2022
COPD Trial in Bois-Guillaume (Nasal high flow)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Nasal high flow
-
Bois-Guillaume, FranceADIR Association
Mar 16, 2022
COPD Trial in China (Revefenacin 175 mcg in 3 ML Inhalation Solution, Placebo inhalation solution QD)
Recruiting
- COPD
- Revefenacin 175 mcg in 3 ML Inhalation Solution
- Placebo inhalation solution QD
-
Beijing, Beijing, China
- +2 more
Feb 22, 2022
Muscle Oxygenation in Chronic Obstructive Pulmonary Disease
Recruiting
- Chronic Obstructive Pulmonary Disease
- +2 more
-
Balıkesir, TurkeyBandırma Onyedi Eylül University, Faculty of Health Sciences, De
Apr 10, 2023
Severe COPD, Dyspnea, Muscle Weakness Trial in Istanbul (Supervised Pulmonary Telerehabilitation, Cognitive Telerehabilitation)
Recruiting
- Severe Chronic Obstructive Pulmonary Disease
- +11 more
- Supervised Pulmonary Telerehabilitation
- Cognitive Telerehabilitation
-
Istanbul, Zeytinburnu, TurkeyYedikule Chest Disease Hospital
Feb 2, 2022
Pulmonary Rehabilitation, Chronic Obstructive Lung Disease, Neuromuscular Electrical Stimulation Trial in Qina (Study Group
Recruiting
- Pulmonary Rehabilitation
- +3 more
- Study Group chest physiotherapy program combined with neuromuscular electrical stimulation (NMES)
- Control Group Chest physical therapy
-
Qinā, EgyptDepartment of P.T for internal medicine, Faculty of Physical The
May 1, 2023
Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, Chronic Bronchitis Trial in United States (Prochymal™, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- +2 more
- Prochymal™
- Placebo
-
Los Angeles, California
- +5 more
Dec 20, 2021
Sleep Apnea, Obstructive, Pulmonary Disease, Chronic Obstructive, Respiration Disorders Trial in United States (Placebo,
Completed
- Sleep Apnea, Obstructive
- +2 more
- Placebo
- Lemborexant 10 mg
-
Glendale, Arizona
- +10 more
Feb 15, 2022
Oral Health and Severe COPD
Active, not recruiting
- COPD
- +4 more
-
Heidelberg, Baden-Württemberg, GermanyUniversity Hospital Heidelberg
Apr 4, 2022
Pulmonary Disease, Chronic Obstructive Trial in London (CHF1535, Formoterol fumarate)
Completed
- Pulmonary Disease, Chronic Obstructive
- CHF1535
- Formoterol fumarate
-
London, United KingdomUCL Medical School
Oct 28, 2021
COPD Severe Trial (Decision Support Intervention, Health Coaching)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease Severe
- Decision Support Intervention
- Health Coaching
- (no location specified)
Aug 25, 2023
COPD (COPD) Trial in China (TQC3721 suspension for inhalation, TQC3721 suspension for inhalation)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- TQC3721 suspension for inhalation
- TQC3721 suspension placebo for inhalation
-
Chongqing, Chongqing, China
- +10 more
Jun 1, 2022
COPD Severe Trial in Suresnes (VOC analysis)
Recruiting
- Chronic Obstructive Pulmonary Disease Severe
- VOC analysis
-
Suresnes, FranceFoch hospital
Jan 13, 2022